Skip to main content

2 Result(s)

within Gerardo Rosati Remove this filter Medicine & Public Health Remove this filter English Remove this filter

and
Your search also matched 5 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you. results, e.g.

Italian survey on cetuximab-based therapy of elderly patients with metastatic colorectal cancer

Include preview-only content

  1. Article

    A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial

    EOX (epirubicin, oxaliplatin, and capecitabine) is one of the standard regimens for metastatic or locally advanced gastric cancer (GC). A new combination based on fractional docetaxel (low-TOX) has been develo...

    Gerardo Rosati, Chiara Alessandra Cella, Luigi Cavanna, Carla Codecà… in Gastric Cancer (2022)

    Download PDF (966 KB) View Article

  2. Article

    Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world

    Although second-line therapy is often considered for advanced gastric cancer patients, the optimal candidates are not well defined.

    Valentina Fanotto, Stefano Cordio, Giulia Pasquini, Caterina Fontanella… in Gastric Cancer (2017)

    Download PDF (553 KB) View Article